• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment).

作者信息

Sutherland C M, Mather F J

出版信息

Cancer. 1985 Mar 15;55(6):1389-97. doi: 10.1002/1097-0142(19850315)55:6<1389::aid-cncr2820550638>3.0.co;2-b.

DOI:10.1002/1097-0142(19850315)55:6<1389::aid-cncr2820550638>3.0.co;2-b
PMID:3971309
Abstract

Between 1948 and 1981, 1230 patients were diagnosed as having regional (skin, muscle, or chest wall attachment) breast cancer, and long-term survival was studied. In all patients, overall survival was 33% at 5 years, 19% at 10 years, and 9% at 20 years. Significant excess mortality due to breast cancer was observed throughout the 20-year follow-up period (P less than 0.002). The risk of breast cancer was highest in the 5-year period following diagnosis, and declined steadily from that time. Additionally, 308 patients diagnosed since 1968 were studied for the effect of prognostic factors. Clinical status of nodes (positive or negative) and presence or absence of peau d'orange were found to be significant prognostic factors in those patients. In those receiving radical surgery, the number of nodes and presence or absence of peau d'orange were found to be of prognostic significance. No effect of race, age, year of diagnosis, site of attachment, type of fixation, ulceration, edema, size of tumor, satellite nodules, or dimpling retraction on breast-cancer-specific survival was observed when the nodal status and peau d'orange were controlled. These data demonstrate that mortality in regional breast cancer is significant and is highly dependent on peau d'orange and nodal status.

摘要

相似文献

1
Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment).
Cancer. 1985 Mar 15;55(6):1389-97. doi: 10.1002/1097-0142(19850315)55:6<1389::aid-cncr2820550638>3.0.co;2-b.
2
The histology of peau d'orange in breast cancer - what are the implications for surgery?乳腺癌橘皮样皮肤改变的组织学——对手术有何影响?
S Afr J Surg. 2012 Jul 11;50(3):75-8. doi: 10.7196/sajs.1103.
3
Charity Hospital experience with long-term survival and prognostic factors in patients with breast cancer with localized or regional disease.慈善医院对局限性或区域性乳腺癌患者长期生存及预后因素的经验。
Ann Surg. 1988 May;207(5):569-80. doi: 10.1097/00000658-198805000-00011.
4
Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy.保乳治疗的T4期局部晚期乳腺癌患者的有效局部控制和长期生存
Ann Surg Oncol. 2004 Sep;11(9):854-60. doi: 10.1245/ASO.2004.02.003. Epub 2004 Aug 16.
5
Long-term survival and prognostic factors in breast cancer patients with localized (no skin, muscle, or chest wall attachment) disease with and without positive lymph nodes.有或无淋巴结阳性的局限性(无皮肤、肌肉或胸壁侵犯)乳腺癌患者的长期生存及预后因素
Cancer. 1986 Feb 1;57(3):622-9. doi: 10.1002/1097-0142(19860201)57:3<622::aid-cncr2820570338>3.0.co;2-c.
6
Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.腋窝淋巴结转移阳性率可预测非转移性乳腺癌患者的生存率。
Acta Oncol. 2008;47(2):232-8. doi: 10.1080/02841860701678761.
7
Radiation therapy following mastectomy for axillary node-positive breast cancer: indication of chest wall irradiation.腋窝淋巴结阳性乳腺癌乳房切除术后的放射治疗:胸壁照射的指征
Oncol Rep. 2000 Sep-Oct;7(5):1107-12. doi: 10.3892/or.7.5.1107.
8
Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes.有 1-3 个阳性腋窝淋巴结的乳腺癌患者区域淋巴结复发的风险因素。
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2093-103. doi: 10.1016/j.ijrobp.2011.01.066. Epub 2011 Apr 27.
9
[Clinical analysis of resectable breast cancer: a report of 6 263 cases].可切除乳腺癌的临床分析:6263例报告
Ai Zheng. 2005 Mar;24(3):327-31.
10
[Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].[早期浸润性乳腺癌治疗中的循证放疗:传统临床特征与生物标志物]
Magy Onkol. 2009 Mar;53(1):7-14. doi: 10.1556/MOnkol.53.2009.1.2.

引用本文的文献

1
SERUM LEPTIN LEVEL IN BREAST CANCER.血清瘦素水平与乳腺癌。
Acta Clin Croat. 2022 Mar;61(1):79-85. doi: 10.20471/acc.2022.61.01.10.
2
Long-Term Survival and Causes of Death After Diagnoses of Common Cancers in 3 Cohorts of US Health Professionals.3 项美国健康专业人员队列研究中常见癌症诊断后的长期生存和死亡原因。
JNCI Cancer Spectr. 2022 Mar 2;6(2). doi: 10.1093/jncics/pkac021.
3
Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer.早期乳腺癌对侧乳腺第二原发性癌的预后因素
Oncol Lett. 2015 Jan;9(1):245-251. doi: 10.3892/ol.2014.2623. Epub 2014 Oct 17.
4
Charity Hospital experience with long-term survival and prognostic factors in patients with breast cancer with localized or regional disease.慈善医院对局限性或区域性乳腺癌患者长期生存及预后因素的经验。
Ann Surg. 1988 May;207(5):569-80. doi: 10.1097/00000658-198805000-00011.
5
Breast cancer. Advances in management.乳腺癌。治疗进展。
Drugs. 1988 May;35(5):584-95. doi: 10.2165/00003495-198835050-00006.